Application 216332
- Type
- ANDA
- Sponsor
- LAURUS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ABACAVIR SULFATE AND LAMIVUDINE | ABACAVIR SULFATE; LAMIVUDINE | TABLET;ORAL | EQ 600MG BASE;300MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 42385-962 | Abacavir and Lamivudine | Abacavir and Lamivudine | Laurus Labs Limited | ANDA | Current |